Random variation in rectal position during radiotherapy for prostate cancer is two to three times greater than that predicted from prostate motion

British Journal of Radiology

Volumn 87, Issue 1042, 2014, Pages

  Scaife, J ^a   Harrison, K ^b   Romanchikova, M ^c   Parker, A ^b   Sutcliffe, M ^d   Bond, S ^e   Thomas, S ^c   Freeman, S ^c   Jena, R ^a   Bates, A ^a   Burnet, N ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTERIOR POSTERIOR AXIS; ARTICLE; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DIGITAL IMAGING AND COMMUNICATIONS IN MEDICINE; HUMAN; IMAGE ANALYSIS; IMAGE PROCESSING; MALE; MEGAVOLTAGE RADIOTHERAPY; MOVEMENT (PHYSIOLOGY); POSITION; PROSTATE CANCER; RADIATION DOSE; RADIOTHERAPY PLANNING SYSTEM; RADIOTHERAPY SOFTWARE; RECTAL POSITION; RECTUM; TREATMENT PLANNING; AGED; ANATOMY AND HISTOLOGY; COMPUTER ASSISTED RADIOTHERAPY; PROCEDURES; PROSTATIC NEOPLASMS; RADIATION RESPONSE; REPRODUCIBILITY;

AGED; HUMANS; MALE; MOVEMENT; PROSTATIC NEOPLASMS; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RECTUM; REPRODUCIBILITY OF RESULTS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84907494208     PISSN: 00071285     EISSN: 1748880X     Source Type: Journal    
DOI: 10.1259/bjr.20140343     Document Type: Article

References (48)

1. Burnet NG, Adams EJ, Fairfoul J, Tudor GS, Hoole AC, Routsis DS, et al. Practical aspects of implementation of helical tomotherapy for intensity-modulated and image-guided radiotherapy. Clin Oncol (R Coll Radiol) 2010; 22: 294-312. doi: 10.1016/j.clon.2010.02.003
2. Chen L, Paskalev K, Xu X, Zhu J, Wang L, Price RA, et al. Rectal dose variation during the course of image-guided radiation therapy of prostate cancer. Radiother Oncol 2010; 95: 198-202. doi: 10.1016/j.radonc.2010.02.023
3. Engels B, Tournel K, Soete G, Storme G. Assessment of rectal distention in radiotherapy of prostate cancer using daily megavoltage CT image guidance. Radiother Oncol 2009; 90: 377-81. doi: 10.1016/j.radonc.2008.12.005
4. Hoogeman MS, van Herk M, de Bois J, Muller-Timmermans P, Koper PC, Lebesque JV. Quantification of local rectal wall displacements by virtual rectum unfolding. Radiother Oncol 2004; 70: 21-30.
5. Lebesque JV, Bruce AM, Kroes AP, Touw A, Shouman RT, van Herk M. Variation in volumes, dose-volume histograms, and estimated normal tissue complication probabilities of rectum and bladder during conformal radiotherapy of T3 prostate cancer. Int J Radiat Oncol Biol Phys 1995; 33: 1109-19.
6. Murthy V, Shukla P, Adurkar P, Master Z, Mahantshetty U, Shrivastava SK. Dose variation during hypofractionated image-guided radiotherapy for prostate cancer: planned versus delivered. J Cancer Res Ther 2011; 7: 162-7. doi: 10.4103/0973-1482.82920
7. Peng C, Ahunbay E, Chen G, Anderson S, Lawton C, Li XA. Characterizing interfraction variations and their dosimetric effects in prostate cancer radiotherapy. Int J Radiat Oncol Biol Phys 2011; 79: 909-14. doi: 10.1016/j.ijrobp.2010.05.008
8. Roeske JC, Forman JD, Mesina CF, He T, Pelizzari CA, Fontenla E, et al. Evaluation of changes in the size and location of the prostate, seminal vesicles, bladder, and rectum during a course of external beam radiation therapy. Int J Radiat Oncol Biol Phys 1995; 33: 1321-9.
9. van Herk M, Bruce A, Kroes AP, Shouman T, Touw A, Lebesque JV. Quantification of organ motion during conformal radiotherapy of the prostate by three dimensional image registration. Int J Radiat Oncol Biol Phys 1995; 33: 1311-20.
10. Hatton JA, Greer PB, Tang C, Wright P, Capp A, Gupta S, et al. Does the planning dosevolume histogram represent treatment doses in image-guided prostate radiation therapy? Assessment with cone-beam computerised tomography scans. Radiother Oncol 2011; 98: 162-8. doi: 10.1016/j.radonc.2011.01.006
11. Kupelian PA, Langen KM, Zeidan OA, Meeks SL, Willoughby TR, Wagner TH, et al. Daily variations in delivered doses in patients treated with radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 2006; 66: 876-82.
12. Barnett GC, West CM, Dunning AM, Elliott RM, Coles CE, Pharoah PD, et al. Normal tissue reactions to radiotherapy: towards tailoring treatment dose by genotype. Nat Rev Cancer 2009; 9: 134-42. doi: 10.1038/nrc2587
13. Bentzen SM, Constine LS, Deasy JO, Eisbruch A, Jackson A, Marks LB, et al. Quantitative Analyses of Normal Tissue Effects in the Clinic (QUANTEC): an introduction to the scientific issues. Int J Radiat Oncol Biol Phys 2010; 76(Suppl. 3): S3-9. doi: 10.1016/j.ijrobp.2009.09.040
14. Jaffray DA, Lindsay PE, Brock KK, Deasy JO, Tomé WA. Accurate accumulation of dose for improved understanding of radiation effects in normal tissue. Int J Radiat Oncol Biol Phys 2010; 76(Suppl. 3): S135-9. doi: 10.1016/j.ijrobp.2009.06.093
15. VoxTox-linking radiation dose at the voxel level with toxicity. An observational study to collect comprehensive toxicity data for patients undergoing image-guided intensity-modulated radiotherapy to the head and neck, prostate, and central nervous system. Protocol version 1.2 May 2013. Available from: http://public.ukcm.org.uk/search/StudyDetail.aspx?StudyID=13716
16. Romanchikova M, Burnet N, Harrison K, Hoole A, Parker A, Thomas S, eds. The challenge of generating DICOM RT data from TomoTherapy archives for the VoxTox study. 2013 IPEM Conference-Data: Storage, Management, Generation and Legislation; 16 April 2013; London, UK.
17. CHHiP-conventional or hypofractionated high dose intensity modulated radiotherapy for prostate cancer. Protocol version 8.0 November 2009.
18. Pivotal-a randomised phase II trial of prostate and pelvis versus prostate alone treatment for locally advanced prostate cancer. Radiotherapy planning document version 3.3 July 2011. [Cited 2 September.] Available from: http://www.controlledtrials.com/ISRCTN48709247/48709247
19. Jena R, Kirkby NF, Burton KE, Hoole AC, Tan LT, Burnet NG. A novel algorithm for the morphometric assessment of radiotherapy treatment planning volumes. Br J Radiol 2010; 83: 44-51. doi: 10.1259/bjr/27674581
20. Bates AM, Scaife JE, Tudor GS, Jena R, Romanchikova M, Dean JC, et al. Image guidance protocols: balancing imaging parameters against scan time. Br J Radiol 2013; 86: 20130385. doi: 10.1259/bjr.20130385
21. Brierley JD, Dawson LA, Sampson E, Bayley A, Scott S, Moseley JL, et al. Rectal motion in patients receiving preoperative radiotherapy for carcinoma of the rectum. Int J Radiat Oncol Biol Phys 2011; 80: 97-102. doi: 10.1016/j.ijrobp.2010.01.042
22. Chong I, Hawkins M, Hansen V, Thomas K, McNair H, O'Neill B, et al. Quantification of organ motion during chemoradiotherapy of rectal cancer using cone-beam computed tomography. Int J Radiat Oncol Biol Phys 2011; 81: e431-8. doi: 10.1016/j.ijrobp.2011.04.060
23. Stasi M, Munoz F, Fiorino C, Pasquino M, Baiotto B, Marini P, et al. Emptying the rectum before treatment delivery limits the variations of rectal dose-volume parameters during 3DCRT of prostate cancer. Radiother Oncol 2006; 80: 363-70.
24. van Herk M. Errors and margins in radiotherapy. Semin Radiat Oncol 2004; 14: 52-64.
25. de Boer HC, van Sornsen de Koste JR, Senan S, Visser AG, Heijmen BJ. Analysis and reduction of 3D systematic and random setup errors during the simulation and treatment of lung cancer patients with CT-based external beam radiotherapy dose planning. Int J Radiat Oncol Biol Phys 2001; 49: 857-68.
26. Creutzberg CL, Althof VG, de Hoog MD, Visser AG, Huizenga H, Wijnmaalen A, et al. A quality control study of the accuracy of patient positioning in irradiation of pelvic fields. Int J Radiat Oncol Biol Phys 1996; 34: 697-708.
27. Antolak JA, Rosen, II, Childress CH, Zagars GK, Pollack A. Prostate target volume variations during a course of radiotherapy. Int J Radiat Oncol Biol Phys 1998; 42: 661-72.
28. Stroom JC, Koper PC, Korevaar GA, van Os M, Janssen M, de Boer HC, et al. Internal organ motion in prostate cancer patients treated in prone and supine treatment position. Radiother Oncol 1999; 51: 237-48.
29. Ten Haken RK, Forman JD, Heimburger DK, Gerhardsson A, McShan DL, Perez-Tamayo C, et al. Treatment planning issues related to prostate movement in response to differential filling of the rectum and bladder. Int J Radiat Oncol Biol Phys 1991; 20: 1317-24.
30. Tinger A, Michalski JM, Cheng A, Low DA, Zhu R, Bosch WR, et al. A critical evaluation of the planning target volume for 3-D conformal radiotherapy of prostate cancer. Int J Radiat Oncol Biol Phys 1998; 42: 213-21.
31. Zelefsky MJ, Crean D, Mageras GS, Lyass O, Happersett L, Ling CC, et al. Quantification and predictors of prostate position variability in 50 patients evaluated with multiple CT scans during conformal radiotherapy. Radiother Oncol 1999; 50: 225-34.
32. Bylund KC, Bayouth JE, Smith MC, Hass AC, Bhatia SK, Buatti JM. Analysis of interfraction prostate motion using megavoltage cone beam computed tomography. Int J Radiat Oncol Biol Phys 2008; 72: 949-56. doi: 10.1016/j.ijrobp.2008.11.009
33. Fiorino C, Di Muzio N, Broggi S, Cozzarini C, Maggiulli E, Alongi F, et al. Evidence of limited motion of the prostate by carefully emptying the rectum as assessed by daily MVCT image guidance with helical tomotherapy. Int J Radiat Oncol Biol Phys 2008; 71: 611-17. doi: 10.1016/j.ijrobp.2008.01.048
34. Dawson LA, Mah K, Franssen E, Morton G. Target position variability throughout prostate radiotherapy. Int J Radiat Oncol Biol Phys 1998; 42: 1155-61.
35. Vigneault E, Pouliot J, Laverdière J, Roy J, Dorion M. Electronic portal imaging device detection of radioopaque markers for the evaluation of prostate position during megavoltage irradiation: a clinical study. Int J Radiat Oncol Biol Phys 1997; 37: 205-12.
36. Crook JM, Raymond Y, Salhani D, Yang H, Esche B. Prostate motion during standard radiotherapy as assessed by fiducial markers. Radiother Oncol 1995; 37: 35-42.
37. Fiorino C, Reni M, Bolognesi A, Bonini A, Cattaneo GM, Calandrino R. Set-up error in supine-positioned patients immobilized with two different modalities during conformal radiotherapy of prostate cancer. Radiother Oncol 1998; 49: 133-41.
38. de Crevoisier R, Tucker SL, Dong L, Mohan R, Cheung R, Cox JD, et al. Increased risk of biochemical and local failure in patients with distended rectum on the planning CT for prostate cancer radiotherapy. Int J Radiat Oncol Biol Phys 2005; 62: 965-73.
39. Song WY, Chiu B, Bauman GS, Lock M, Rodrigues G, Ash R, et al. Prostate contouring uncertainty in megavoltage computed tomography images acquired with a helical tomotherapy unit during image-guided radiation therapy. Int J Radiat Oncol Biol Phys 2006; 65: 595-607.
40. Rasch C, Barillot I, Remeijer P, Touw A, van Herk M, Lebesque JV. Definition of the prostate in CT and MRI: a multi-observer study. Int J Radiat Oncol Biol Phys 1999; 43: 57-66.
41. Roach M 3rd, Faillace-Akazawa P, Malfatti C, Holland J, Hricak H. Prostate volumes defined by magnetic resonance imaging and computerized tomographic scans for threedimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 1996; 35: 1011-18.
42. Padhani AR, Khoo VS, Suckling J, Husband JE, Leach MO, Dearnaley DP. Evaluating the effect of rectal distension and rectal movement on prostate gland position using cine MRI. Int J Radiat Oncol Biol Phys 1999; 44: 525-33.
43. Thomas SJ, Ashburner M, Tudor GS, Treeby J, Dean J, Routsis D, et al. Intra-fraction motion of the prostate during treatment with helical tomotherapy. Radiother Oncol 2013; 109: 482-6. doi: 10.1016/j.radonc.2013.09.011
44. White EA, Brock KK, Jaffray DA, Catton CN. Inter-observer variability of prostate delineation on cone beam computerised tomography images. Clin Oncol (R Coll Radiol) 2009; 21: 32-8. doi: 10.1016/j.clon.2008.11.007
45. Foroudi F, Haworth A, Pangehel A, Wong J, Roxby P, Duchesne G, et al. Inter-observer variability of clinical target volume delineation for bladder cancer using CT and cone beam CT. J Med Imaging Radiat Oncol 2009; 53: 100-6. doi: 10.1111/j.1754-9485.2009.02044.x
46. Lütgendorf-Caucig C, Fotina I, Stock M, Pötter R, Goldner G, Georg D. Feasibilityof CBCT-based target and normal structure delineation in prostate cancer radiotherapy: multi-observer and image multi-modality study. Radiother Oncol 2011; 98: 154-61. doi: 10.1016/j.radonc.2010.11.016
47. Thomas SJ, Eyre KR, Tudor GS, Fairfoul J. Dose calculation software for helical tomotherapy, utilizing patient CT data to calculate an independent three-dimensional dose cube. Med Phys 2012; 39: 160-7. doi: 10.1118/1.3668061
48. Thor M, Bentzen L, Hysing LB, Ekanger C, Helle SI, Karlsdóttir Á, et al. Prediction of rectum and bladder morbidity following radiotherapy of prostate cancer based on motion-inclusive dose distributions. Radiother Oncol 2013; 107: 147-52. doi: 10.1016/j.radonc.2013.03.029